Juan Carlos Calvo
University of Buenos Aires
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Juan Carlos Calvo.
International Journal of Molecular Sciences | 2011
Pablo Calzadilla; Daiana Sapochnik; Soledad Cosentino; Virginia E. Diz; Lelia E. Dicelio; Juan Carlos Calvo; Liliana N. Guerra
Oxidative stress plays a critical role in the pathogenesis of diabetes, hypertension and atherosclerosis. Some authors reported that fat accumulation correlates to systemic oxidative stress in humans and mice, but the relationship of lipid production and oxidative metabolism is still unclear. In our laboratory we used 3T3-L1 preadipocytes, which are able to differentiate into mature adipocytes and accumulate lipids, as obesity model. We showed that intracellular reactive oxygen species (ROS) and antioxidant enzymes superoxide dismutase (SOD) and glutathione peroxidase (GPx) activities increased in parallel with fat accumulation. Meanwhile N-acetylcysteine (NAC), a well known antioxidant and Glutathione (GSH) precursor, inhibited ROS levels as well as fat accumulation in a concentration-dependent manner. NAC also inhibited both adipogenic transcription factors CCAAT/enhancer binding protein beta (C/EBP β) and peroxisomal proliferator activated receptor gamma (PPAR γ) expression; we suggested that intracellular GSH content could be responsible for these effects.
Journal of Experimental & Clinical Cancer Research | 2017
Sabrina Johanna Fletcher; Paula Alejandra Sacca; Mercedes Pistone-Creydt; Federico Andrés Coló; María Florencia Serra; Flavia Eliana Santino; Corina V. Sasso; Constanza M. López-Fontana; Rubén W. Carón; Juan Carlos Calvo; Virginia Pistone-Creydt
BackgroundAdipose microenvironment is involved in signaling pathways that influence breast cancer. We aim to characterize factors that are modified: 1) in tumor and non tumor human breast epithelial cell lines when incubated with conditioned media (CMs) from human breast cancer adipose tissue explants (hATT) or normal breast adipose tissue explants (hATN); 2) in hATN-CMs vs hATT-CMs; 3) in the tumor associated adipocytes vs. non tumor associated adipocytes.MethodsWe used hATN or hATT- CMs on tumor and non-tumor breast cancer cell lines. We evaluated changes in versican, CD44, ADAMTS1 and Adipo R1 expression on cell lines or in the different CMs. In addition we evaluated changes in the morphology and expression of these factors in slices of the different adipose tissues. The statistical significance between different experimental conditions was evaluated by one-way ANOVA. Tukey’s post-hoc tests were performed within each individual treatment.ResultshATT-CMs increase versican, CD44, ADAMTS1 and Adipo R1 expression in breast cancer epithelial cells. Furthermore, hATT-CMs present higher levels of versican expression compared to hATN-CMs. In addition, we observed a loss of effect in cellular migration when we pre-incubated hATT-CMs with chondroitinase ABC, which cleaves GAGs chains bound to the versican core protein, thus losing the ability to bind to CD44. Adipocytes associated with the invasive front are reduced in size compared to adipocytes that are farther away. Also, hATT adipocytes express significantly higher amounts of versican, CD44 and Adipo R1, and significantly lower amounts of adiponectin and perilipin, unlike hATN adipocytes.ConclusionsWe conclude that hATT secrete a different set of proteins compared to hATN. Furthermore, versican, a proteoglycan that is overexpressed in hATT-CMs compared to hATN-CMs, might be involved in the tumorogenic behavior observed in both cell lines employed. In addition, we may conclude that adipocytes from the tumor microenvironment show a less differentiated state than adipocytes from normal microenvironment. This would indicate a loss of normal functions in mature adipocytes (such as energy storage), in support of others that might favor tumor growth.
Journal of Molecular Histology | 2012
Vanina Fontana; Tamara A. Coll; Cristian Sobarzo; Leticia Perez Tito; Juan Carlos Calvo; Elisa Cebral
During early placentation, matrix metalloproteinases (MMPs) play important roles in decidualization, trophoblast migration, invasion, angiogenesis, vascularization and extracellular matrix (ECM) remodeling of the endometrium. The aim of our study was to analyze the localization, distribution and differential expression of MMP-2 and -9 in the organogenic implantation site and to evaluate in vivo and in vitro decidual MMP-2 and -9 activities on day 10 of gestation in CF-1 mouse. Whole extracts for Western blotting of organogenic E10-decidua expressed MMP-2 and -9 isoforms. MMP-2 immunoreactivity was found in a granular and discrete pattern in ECM of mesometrial decidua (MD) near maternal blood vessels and slightly in non-decidualized endometrium (NDE). Immunoexpression of MMP-9 was also detected in NDE, in cytoplasm of decidual cells and ECM of vascular MD, in trophoblastic area and in growing antimesometrial deciduum. Gelatin zymography showed that MMP-9 activity was significantly lower in CM compared to the active form of direct (not cultured) and cultured decidua. The decidual active MMP-9 was significantly higher than the active MMP-2. These results show differential localization, protein expression and enzymatic activation of MMPs, suggesting specific roles for MMP-2 and MMP-9 in decidual and trophoblast tissues related to organogenic ECM remodeling and vascularization during early establishment of mouse placentation.
Molecular and Cellular Endocrinology | 1987
Martin D. Crespi; Juan P. Radicella; Alberto Baldi; Eduarde H. Charreau; Juan Carlos Calvo
The action of luteinizing hormone on topoisomerase I activity from rat Leydig cells was studied. Stimulation of the enzyme was observed after long-term (24 and 48 h) gonadotrophin treatment in in vivo experiments. No change could be detected for shorter times than 12 h using two different experimental approaches. Topoisomerase I was stimulated by cAMP in a whole cell extract in a phosphorylation-dependent manner. These results suggest that topoisomerase I could be a target for nuclear events induced by peptide hormone action.
Biocell | 2010
Vanina Fontana; Melisa Sanchez; Elisa Cebral; Juan Carlos Calvo
Breast Cancer Research and Treatment | 2011
María Cecilia Bottino; Juan P. Cerliani; Sebastián Giulianelli; Rocío Soldati; Carolina Mondillo; María A. Gorostiaga; Omar Pedro Pignataro; Juan Carlos Calvo; Silvio Gutkind; Panomwat Amornphimoltham; Alfredo A. Molinolo; Isabel Alicia Luthy; Claudia Lanari
Medical Science Monitor | 2003
Marisa Zallocchi; Pilar Igarreta; Juan Carlos Calvo; Nancy Amaral Rebouças; María Christina Christina Damasco
Clinical & Translational Oncology | 2013
Virginia Pistone Creydt; Sabrina Johanna Fletcher; Jimena Giudice; Ariana Bruzzone; Norma Alejandra Chasseing; Eduardo González; Paula Alejandra Sacca; Juan Carlos Calvo
Biocell | 2007
Vanina Laura Julianelli; Liliana N. Guerra; Juan Carlos Calvo
Biocell | 2006
Marisa Zallocchi; María C. Damasco; Juan Carlos Calvo; Carlos P. Lantos; Laura Matković